HOLLEY INC. — Key Metrics
6 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)↑+152.9% +$0
$0
Book Value Per Share↑+10.5% +$0
$4
Free Cash Flow Per Share↑+300.1% +$0
$0
Cash Per Share↓-23.2% -$0
$0
Revenue Per Share↓-33.6% -$3
$5
OCF Per Share↑+60.5% +$0
$0
Return on Equity↑+14.4pts
4.4%
Return on Assets↑+4.1pts
1.7%
Return on Invested Capital↓-1.0pts
5.7%
Debt to Equity↓-45.1% -$1
1.15
Current Ratio↓-13.6% -$0
2.75
Quick Ratio↓-17.4% -$0
0.96
Asset Turnover↓-12.9% -$0
0.53
Days Sales Outstanding
21.89
Days Payables Outstanding↑+53.8% +$22
63.19
Days Inventory On Hand↑+30.0% +$50
216.16
Cash Conversion Cycle
170.17
R&D / Revenue↓-1.0pts
3.1%
Capex / Revenue↓-0.2pts
2.0%
Working Capital↑+0.6% +$1M
$201M
Net Current Asset Value↑+33.2% +$198M
$-399M
Invested Capital↑+2.4% +$23M
$965M
OCF / Net Income↑+403.1% +$3
2.41
FCF / Net Income↑+855.6% +$2
1.77
Accruals Ratio (Sloan)↑+1.8pts
-2.3%
Net Debt↓-20.4% -$123M
$479M
Net Debt / EBITDA↓-23.1% -$2
5.19
Interest Coverage↓-19.7% -$0
1.59
Cash Coverage↑+61.7% +$0
0.89
Capex Coverage↑+164.8% +$2
3.75
Tangible Common Equity↑+41.3% +$225M
$-320M
TCE / Total Assets↑+18.2pts
-27.5%
Goodwill / Total Assets↓-2.5pts
32.0%
NOPAT↓-9.8% -$6M
$55M
Cash ROIC↑+2.8pts
3.5%
WC / Revenue↑+3.9pts
32.8%
Capex / D&A↓-3.9% -$0
1.27
Reinvestment Rate↓-155.4pts
3.2%
Asset Growth vs Revenue Growth↑+26.3pts
0.8%
Revenue 5Y CAGR
4.0%
EPS 5Y CAGR
-10.2%
FCF 5Y CAGR
-15.6%
EBITDA 5Y CAGR
-0.2%
Book Value 5Y CAGR
13.3%
Stock Price (FY-end)↓-68.2% -$9
$4
Market Cap↓-57.6% -$673M
$496M
P/E Ratio
25.86
P/S Ratio↓-52.1% -$1
0.81
P/B Ratio↓-71.2% -$3
1.10
P/OCF Ratio↓-80.2% -$43
10.73
P/FCF Ratio↓-92.1% -$169
14.63
Enterprise Value↓-44.9% -$795M
$975M
EV / EBITDA↓-46.8% -$9
10.57
EV / Sales↓-37.8% -$1
1.59
EV / FCF↓-89.7% -$250
28.75
FCF Yield↑+6.3pts
6.8%
R&D Yield↑+1.4pts
3.8%
Capex Yield↑+1.2pts
2.5%
Operating Leverage↑+99520.2% +$247
246.61
Graham Number
$4
Shares Variation (YoY)↓-31.6pts
1.4%
Beta (5Y)↑+585.2% +$1
0.99
Cost of Equity↑+4.2pts
9.5%
Cost of Debt (after tax)↑+1.9pts
6.7%
WACC↑+3.0pts
8.1%
ROIC - WACC Spread↓-3.9pts
-2.4%
52W High↓-67.4% -$9
$4
52W Low↓-81.2% -$8
$2
Trailing Return 1Y↑+7.9pts
37.7%
Trailing Return 5Y
-58.7%
F-Score (Piotroski)↑+0.0% +$0
6.00
M-Score (Beneish)
-3.08
Z-Score (Altman)↓-16.8% -$0
1.46
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Beat / Miss vs Estimate
Stock Price on Earnings Dates
HOLLEY INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | — | — | — | — | 1.64% | 4.81% |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | — | — | — | — | — | — |
| R&D Tax Credits | — | — | — | — | 0.46% | 1.25% |
| FDII Deduction | — | — | — | — | 7.75% | 0.67% |
| SBC (Nondeductible) | — | — | — | — | 2.17% | 0.30% |
| Valuation Allowance Change | — | — | — | — | 0.00% | 0.00% |
| Tax Law Change | — | — | — | — | 0.00% | 0.00% |
| Effective Tax Rate | — | — | — | — | 11.52% | 33.01% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $8.8M | $10.4M | $4.5M | $8.4M | −$3.0M | $9.5M |
| Income Taxes Paid (Cash) | $3.2M | $10.6M | $6.8M | $16.0M | $11.1M | $10.4M |
HOLLEY INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.